WALTHAM, Mass., June 11, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced the appointment of Melissa Bradford Klug as senior vice president of business development and strategy. Ms. Klug brings a wealth of hands-on business development, licensing and strategic partnering experience, as well as extensive leadership skills to AMAG’s executive team. She joins AMAG today from Mallinckrodt Pharmaceuticals, where she completed a number of significant transactions, including two corporate development transactions within six months of Mallinckrodt’s spin out of Covidien. Ms. Klug will report directly to Frank Thomas, executive vice president and chief operating officer of AMAG, whose role will be expanded to include corporate development.
Help employers find you! Check out all the jobs and post your resume.
